Flextra DS
Flextra DS

Flextra DS review

Flextra DS, which is commonly prescribed as acetaminophen and phenyltoloxamine, is commonly used to treat the aches, pains, fever, sneezing, cough, stuffy nose, and congestion associated with allergies and hay fever. Flextra DS contains a fever reducer and an antihistamine.

Flextra DS is not appropriate for everyone. A thorough medical history should be assessed prior to prescribing this medication. Patients with a medical history which includes liver disease, kidney disease, heavy drinking, diabetes, glaucoma, difficulty urinating, stomach ulcers, high blood pressure, heart disease, or an overactive thyroid may not be able to take Flextra DS or may require careful monitoring while undergoing drug therapy with this medication, depending on the condition and the severity of the condition. This medication is not highly recommended for children.

The American Food and Drug Administration rated Flextra DS as a pregnancy risk category C. It has yet to be determined whether or not this medication will cause harm or birth defects in an unborn baby. It has yet to be determined whether or not this medication will pass through the mother’s breast milk and affect a nursing baby. The prescribing physician should not prescribe this medication to women who are pregnant, nursing, or are likely to become pregnant.

There is a risk of side effects associated with Flextra DS, some of which are severe. A patient who is experiencing a serious side effect or an allergic reaction should seek immediate emergency medical attention. An allergic reaction will present with symptoms such as facial swelling, including swelling of the lips, mouth, tongue, or throat, hives, and difficulty breathing. Other serious side effects which require emergency medical treatment include symptoms such as liver damage, jaundice, blood problems, and low blood sugar.

Other less serious side effects typically do not require emergency medical attention but should be reported to the prescribing physician. Patients should be encouraged to report all side effects. Less serious side effects include symptoms such as dry eyes, dizziness, dry mouth or nose, difficulty urinating, blurry vision, and excitability in children. Less serious side effects can often be reduced to a tolerable level by reducing the dosage of Flextra DS.

Flextra DS should be taken exactly as it has been prescribed. If the patient misses a dose, the dose should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped to avoid the potential for an overdose. The patient should never take a double dose of this medication. If an overdose is suspected, the patient should seek immediate emergency medical attention. An overdose will present with symptoms which include nausea, vomiting, diarrhea, abdominal pain, sweating, confusion agitation, tremors, hallucinations, sedation, insomnia, seizures, and irregular and fast heart beat.

There is a risk of negative drug interactions associated with Flextra DS. Thorough medical history should be understood prior to prescribing this medication. Patients should be urged to inquire with the prescribing physician before taking any new medications, including over the counter medications and herbal remedies. Medications with known negative interactions with Flextra DS include diet pills, anxiety medication, alcohol, sedative, cough and cold medicine, allergy medication, pain relievers, or muscle relaxants. Patients who have taken an MAOI in the previous 14 days may experience life threatening interactions if the take Flextra DS. These medications must have at least 14 days between first and last doses.

Flextra DS has the following structural formula:

Chemical structure of Flextra DS

 Flextra DS available : 500mg tablets

  Your Flextra DS review